Golabi, P., Stepanova, M., Pham, H. T., Cable, R., Rafiq, N., Bush, H., . . . Younossi, Z. M. (2018). Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD). BMJ Open Gastroenterol.

Golabi, Pegah, Maria Stepanova, Huong T. Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll, and Zobair M. Younossi. "Non-alcoholic Steatofibrosis (NASF) Can Independently Predict Mortality in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)." BMJ Open Gastroenterol 2018.

Golabi, Pegah, et al. "Non-alcoholic Steatofibrosis (NASF) Can Independently Predict Mortality in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)." BMJ Open Gastroenterol 2018.